SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-15-003760
Filing Date
2015-11-05
Accepted
2015-11-05 16:10:34
Documents
2
Period of Report
2015-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CLOVIS ONCOLOGY, INC. 8-K a51218664.htm 8-K 16549
2 EXHIBIT 99.1 a51218664ex99_1.htm EX-99.1 68392
  Complete submission text file 0001157523-15-003760.txt   86233
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 151200726
SIC: 2834 Pharmaceutical Preparations